Position-specific N- and O-glycosylation of the reactive center loop impacts neutrophil elastase-mediated proteolysis of corticosteroid-binding globulin
Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved..
Corticosteroid-binding globulin (CBG) delivers anti-inflammatory cortisol to inflamed tissues through proteolysis of an exposed reactive center loop (RCL) by neutrophil elastase (NE). We previously demonstrated that RCL-localized Asn347-linked N-glycans impact NE proteolysis, but a comprehensive structure-function characterization of the RCL glycosylation is still required to better understand CBG glycobiology. Herein, we first performed RCL-centric glycoprofiling of serum-derived CBG to elucidate the Asn347-glycans and then used molecular dynamics simulations to study their impact on NE proteolysis. Importantly, we also identified O-glycosylation (di/sialyl T) across four RCL sites (Thr338/Thr342/Thr345/Ser350) of serum CBG close to the NE-targeted Val344-Thr345 cleavage site. A restricted N- and O-glycan co-occurrence pattern on the RCL involving exclusively Asn347 and Thr338 glycosylation was experimentally observed and supported in silico by modeling of a CBG-GalNAc-transferase (GalNAc-T) complex with various RCL glycans. GalNAc-T2 and GalNAc-T3 abundantly expressed by liver and gall bladder, respectively, showed in vitro a capacity to transfer GalNAc (Tn) to multiple RCL sites suggesting their involvement in RCL O-glycosylation. Recombinant CBG was then used to determine roles of RCL O-glycosylation through longitudinal NE-centric proteolysis experiments, which demonstrated that both sialoglycans (disialyl T) and asialoglycans (T) decorating Thr345 inhibit NE proteolysis. Synthetic RCL O-glycopeptides expanded on these findings by showing that Thr345-Tn and Thr342-Tn confer strong and moderate protection against NE cleavage, respectively. Molecular dynamics substantiated that short Thr345-linked O-glycans abrogate NE interactions. In conclusion, we report on biologically relevant CBG RCL glycosylation events, which improve our understanding of mechanisms governing cortisol delivery to inflamed tissues.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:300 |
---|---|
Enthalten in: |
The Journal of biological chemistry - 300(2024), 1 vom: 11. Jan., Seite 105519 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Chernykh, Anastasia [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 07.02.2024 Date Revised 10.02.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.jbc.2023.105519 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM365334758 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM365334758 | ||
003 | DE-627 | ||
005 | 20240210232934.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jbc.2023.105519 |2 doi | |
028 | 5 | 2 | |a pubmed24n1287.xml |
035 | |a (DE-627)NLM365334758 | ||
035 | |a (NLM)38042488 | ||
035 | |a (PII)S0021-9258(23)02547-4 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Chernykh, Anastasia |e verfasserin |4 aut | |
245 | 1 | 0 | |a Position-specific N- and O-glycosylation of the reactive center loop impacts neutrophil elastase-mediated proteolysis of corticosteroid-binding globulin |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 07.02.2024 | ||
500 | |a Date Revised 10.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved. | ||
520 | |a Corticosteroid-binding globulin (CBG) delivers anti-inflammatory cortisol to inflamed tissues through proteolysis of an exposed reactive center loop (RCL) by neutrophil elastase (NE). We previously demonstrated that RCL-localized Asn347-linked N-glycans impact NE proteolysis, but a comprehensive structure-function characterization of the RCL glycosylation is still required to better understand CBG glycobiology. Herein, we first performed RCL-centric glycoprofiling of serum-derived CBG to elucidate the Asn347-glycans and then used molecular dynamics simulations to study their impact on NE proteolysis. Importantly, we also identified O-glycosylation (di/sialyl T) across four RCL sites (Thr338/Thr342/Thr345/Ser350) of serum CBG close to the NE-targeted Val344-Thr345 cleavage site. A restricted N- and O-glycan co-occurrence pattern on the RCL involving exclusively Asn347 and Thr338 glycosylation was experimentally observed and supported in silico by modeling of a CBG-GalNAc-transferase (GalNAc-T) complex with various RCL glycans. GalNAc-T2 and GalNAc-T3 abundantly expressed by liver and gall bladder, respectively, showed in vitro a capacity to transfer GalNAc (Tn) to multiple RCL sites suggesting their involvement in RCL O-glycosylation. Recombinant CBG was then used to determine roles of RCL O-glycosylation through longitudinal NE-centric proteolysis experiments, which demonstrated that both sialoglycans (disialyl T) and asialoglycans (T) decorating Thr345 inhibit NE proteolysis. Synthetic RCL O-glycopeptides expanded on these findings by showing that Thr345-Tn and Thr342-Tn confer strong and moderate protection against NE cleavage, respectively. Molecular dynamics substantiated that short Thr345-linked O-glycans abrogate NE interactions. In conclusion, we report on biologically relevant CBG RCL glycosylation events, which improve our understanding of mechanisms governing cortisol delivery to inflamed tissues | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a N-glycosylation | |
650 | 4 | |a O-glycosylation | |
650 | 4 | |a corticosteroid-binding globulin | |
650 | 4 | |a cortisol | |
650 | 4 | |a glycosylation | |
650 | 4 | |a neutrophil elastase | |
650 | 4 | |a proteolysis | |
650 | 4 | |a reactive center loop | |
650 | 7 | |a Hydrocortisone |2 NLM | |
650 | 7 | |a WI4X0X7BPJ |2 NLM | |
650 | 7 | |a Leukocyte Elastase |2 NLM | |
650 | 7 | |a EC 3.4.21.37 |2 NLM | |
650 | 7 | |a Polysaccharides |2 NLM | |
650 | 7 | |a Transcortin |2 NLM | |
650 | 7 | |a 9010-38-2 |2 NLM | |
650 | 7 | |a SERPINA6 protein, human |2 NLM | |
650 | 7 | |a ELANE protein, human |2 NLM | |
650 | 7 | |a EC 3.4.21.37 |2 NLM | |
700 | 1 | |a Abrahams, Jodie L |e verfasserin |4 aut | |
700 | 1 | |a Grant, Oliver C |e verfasserin |4 aut | |
700 | 1 | |a Kambanis, Lucas |e verfasserin |4 aut | |
700 | 1 | |a Sumer-Bayraktar, Zeynep |e verfasserin |4 aut | |
700 | 1 | |a Ugonotti, Julian |e verfasserin |4 aut | |
700 | 1 | |a Kawahara, Rebeca |e verfasserin |4 aut | |
700 | 1 | |a Corcilius, Leo |e verfasserin |4 aut | |
700 | 1 | |a Payne, Richard J |e verfasserin |4 aut | |
700 | 1 | |a Woods, Robert J |e verfasserin |4 aut | |
700 | 1 | |a Thaysen-Andersen, Morten |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Journal of biological chemistry |d 1945 |g 300(2024), 1 vom: 11. Jan., Seite 105519 |w (DE-627)NLM000004995 |x 1083-351X |7 nnns |
773 | 1 | 8 | |g volume:300 |g year:2024 |g number:1 |g day:11 |g month:01 |g pages:105519 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jbc.2023.105519 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 300 |j 2024 |e 1 |b 11 |c 01 |h 105519 |